Bausch Health price target raised to $10 from $8.50 at RBC Capital
PremiumThe FlyBausch Health price target raised to $10 from $8.50 at RBC Capital
18d ago
Bausch Health call volume above normal and directionally bullish
Premium
The Fly
Bausch Health call volume above normal and directionally bullish
23d ago
Bausch Health turns down bondholders’ debt proposals, WSJ reports
Premium
The Fly
Bausch Health turns down bondholders’ debt proposals, WSJ reports
24d ago
Bausch Health announces Health Canada approval of CABTREO topical treatment
PremiumThe FlyBausch Health announces Health Canada approval of CABTREO topical treatment
2M ago
Paulson buys Everbridge, cuts Anglogold in Q2
Premium
The Fly
Paulson buys Everbridge, cuts Anglogold in Q2
3M ago
Bausch’s eye-care spinoff plans stuck in standoff with creditors, WSJ reports
Premium
The Fly
Bausch’s eye-care spinoff plans stuck in standoff with creditors, WSJ reports
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100